Ownership history in FORMULA GROWTH LTD · 24 quarters on record
This page tracks every 13F SEC filing in which FORMULA GROWTH LTD reported a position in ORTHOPEDIATRICS CORP (KIDS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 81,000 | -4,620 | -5.4% | 0.53% | $1.5M | $18.53 |
| 2024 Q2 | REDUCED | 85,620 | -14,950 | -14.9% | 0.89% | $2.5M | $28.76 |
| 2024 Q1 | REDUCED | 100,570 | -300 | -0.3% | 0.94% | $2.9M | $29.16 |
| 2023 Q4 | REDUCED | 100,870 | -24,100 | -19.3% | 1.05% | $3.3M | $32.51 |
| 2023 Q3 | REDUCED | 124,970 | -1,313 | -1.0% | 1.36% | $4.0M | $32.00 |
| 2023 Q2 | REDUCED | 126,283 | -3,975 | -3.1% | 1.76% | $5.5M | $43.85 |
| 2023 Q1 | REDUCED | 130,258 | -600 | -0.5% | 1.86% | $5.8M | $44.29 |
| 2022 Q4 | REDUCED | 130,858 | -5,200 | -3.8% | 1.47% | $5.2M | $39.73 |
| 2022 Q3 | ADDED | 136,058 | +15,500 | +12.9% | 1.79% | $6.3M | $46.14 |
| 2022 Q2 | REDUCED | 120,558 | -10,000 | -7.7% | 1.44% | $5.2M | $43.15 |
As of 2025 Q4 — sorted by position size